Home / Inspections / 1225278

FDA Inspection 1225278 — Hospira Zagreb d.o.o.

Hospira Zagreb d.o.o. — FEI 3010630287

The FDA completed an inspection of Hospira Zagreb d.o.o. on November 7, 2023 in Brdovec. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Brdovec (Croatia)

Facility

Other inspections at this facility

  • 1327036 (VAI Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1226933 (NAI Thu Dec 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123692 (VAI Fri Mar 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1051780 (VAI Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources